Parvovirus B19 DNA is frequently present in recombinant coagulation factor VIIi products
Eis-Hübinger, A.M.; Sasowski, U.; Brackmann, H.H.; Kaiser, R.; Matz, B.; Schneweis, K.E.
Thrombosis and Haemostasis 76(6): 1120
1996
ISSN/ISBN: 0340-6245 PMID: 8972042 Document Number: 461700
Document emailed within 1 workday
Related Documents
Liebe, S. 1982: Activation of the antihemophilic globulin a (factor VIII). 2. Effect of ampholine on the course of blood coagulation and the molecular conformation of factor VIIi Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 37(4): 110-116Lee, C.A.; Owens, D.; Bray, G.; Giangrande, P.; Collins, P.; Hay, C.; Gomperts, E.; Schroth, P.; Barrowcliffe, T. 1999: Pharmacokinetics of recombinant factor VIIi (recombinate) using one-stage clotting and chromogenic factor VIIi assay Thrombosis and Haemostasis 82(6): 1644-1647
Fijnvandraat, K.; Berntorp, E.; ten Cate, J.W.; Johnsson, H.; Peters, M.; Savidge, G.; Tengborn, L.; Spira, J.; Stahl, C. 1997: Recombinant, B-domain deleted factor VIII (r-VIII SQ): pharmacokinetics and initial safety aspects in hemophilia A patients Thrombosis and Haemostasis 77(2): 298-302
Mahasandana, C.; Suvatte, V.; Püng-amritt, P.; Tuchinda, S. 1979: Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families Southeast Asian Journal of Tropical Medicine and Public Health 10(2): 243-247
Brown, J.E.; Carton, C.L.; Hougie, C. 1981: The effect of naturally occurring antibodies to factor VIIi on an immunoradiometric assay for factor VIIi coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIIi inhibit Journal of Laboratory and Clinical Medicine 97(1): 65-71
Laurian, Y.; Dussaix, E.; Parquet, A.; Chalvon-Demersay, A.; d'Oiron, R.; Tchernia, G. 1994: Transmission of human parvovirus B19 by plasma derived factor VIIi concentrates Nouvelle Revue Francaise d'Hematologie 36(6): 449-453
Kamphuisen, P.W.; Eikenboom, H.C.; Rosendaal, F.R.; Bertina, R.M. 2001: High concentration of coagulation factor VIIi as a risk factor for thrombosis Nederlands Tijdschrift Voor Geneeskunde 145(46): 2213-2217
Takahashi, I.; Furuta, M.; Mizuno, S.; Takamatsu, J.; Kamiya, T. 1993: Effect of substrate and diluent for factor VIIi activity in highly purified factor VIIi concentrate and patient plasma infused factor VIIi concentrate Rinsho Byori. Japanese Journal of Clinical Pathology 41(7): 825-830
Muntean, W. 1984: Purified complex of factor VIII coagulant moiety and phospholipid: high factor VIII coagulant activity in factor VIII inhibitor plasma Wiener Klinische Wochenschrift 96(22): 829-832
Tusell, J.M. 1993: Recombinant factor VIIi Sangre 38(2): 139-142
Tran, T.H.; Duckert, F. 1983: Dissociation of factor VIIi procoagulant antigen VIII:CAg and factor VIIi related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag Thrombosis and Haemostasis 50(2): 547-551
Klein, U. 1991: Production and characterization of recombinant factor VIIi Seminars in Hematology 28(2 Suppl 1: 17-21
Lutze, G.; Schlote, A.; Mittler, U. 1980: Determination of coagulation factor VIIi inhibitors Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 35(8): 330-336
Hilgartner, M.W. 1991: The need for recombinant factor VIII: historical background and rationale Seminars in Hematology 28(2 Suppl 1: 6-9
Fournel, M.A. 1991: Preclinical and in vitro studies of recombinant factor VIIi Seminars in Hematology 28(2 Suppl 1: 22-26
Berntorp, E. 1997: Second generation, B-domain deleted recombinant factor VIII Thrombosis and Haemostasis 78(1): 256-260
Kaufman, R.J.; Pipe, S.W.; Tagliavacca, L.; Swaroop, M.; Moussalli, M. 1997: Biosynthesis, assembly and secretion of coagulation factor VIIi Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 8(Suppl 2): S3-14
Kaufman, R.J.; Pipe, S.W.; Tagliavacca, L.; Swaroop, M.; Moussalli, M. 1997: Biosynthesis, assembly and secretion of coagulation factor VIII Blood Coagulation and Fibrinolysis 8(Suppl. 2): S3-S14
Hay, C.R. 2000: Porcine factor VIII: past, present and future Haematologica 85(10 Suppl): 21-24; Discussion: 24-25
Briseid, G.; Arntzen, F.C. 1995: Factor VIIi preparation produced by recombinant DNA-technology is approved in Norway Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(15): 1849-1851